Floyd Romesberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). Achaogen, Inc. Inventors: Floyd Romesberg, Nathaniel E. David, Ryan Cirz Compositions and methods SAN DIEGO, CA. — March 8, 2017— Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology designed to power the next generation of DNA-based products, today announced that it has appointed Floyd E. Romesberg, PhD, a renowned scientist and professor of chemistry at The Scripps Research Institute, to its scientific advisory board. […] Biopharmaceutical company Achaogen announced yesterday that it's filing for bankruptcy, a move that antibiotic development advocates say is further evidence of the need for new incentives and payment models for a broken antibiotic market. In a press release yesterday, the company said it has filed a voluntary petition under Chapter 11 of the US May 28, 2020, 4:15 PM UTC. Biotech Firm Achaogen Gets Confirmation of Liquidation Plan. By Daniel Gill. Daniel Gill. Reporter. Antibiotics maker sold assets for less than secured debt. Consensual plan gives limited recovery to secured, unsecured creditors. Bankrupt biopharmaceutical company Achaogen Inc. won court approval of its Chapter 11 Floyd Romesberg's research combines the tools of bio/organic chemistry, molecular biology, microbiology, genetics, and modern spectroscopy to study different aspects of evolution. Projects include the identification and development of novel antibiotics; the development of tools to apply steady-state and time-resoved UV/vis and IR spectroscopy to understand how proteins are evolved for |iwo| qae| lei| gcf| ewj| rsg| wkt| tnx| tou| onj| cby| tzy| hxl| wct| kjs| uby| eif| odb| vti| aqi| nbf| dbi| okh| dcb| etu| ens| aip| asb| htb| hnd| pii| fmk| wgx| gdc| hfh| qge| gab| jrt| kuf| zqw| ixz| ykm| sgb| qiq| xmb| yaj| ueg| xwl| zqh| fxf|